The Dow Jones Sustainability Index provides an in-depth measurement of how sustainable a company’s operations are. Beyond financial, environmental and social factors, the Index evaluates important aspects such as best practice within Innovation Management, Research & Development, Environmental policy & management, Stakeholder Engagement, and much more.

“The factors evaluated are important in assessing whether companies will be successful and survive in ever-changing market conditions, and thus, critically, whether they're likely to increase shareholder value. Seen in this light, it's fantastic to be recognized as leader of the Biotech sector,” says Mads Bodenhoff, Vice President Finance of Novozymes.

He continues: “Bioinnovation has the potential to be part of the solution to some of the most pressing global challenges. In Novozymes we expect sustainability to be a very significant lever in support of our overall efforts to grow the business. Therefore we're very pleased to be recognized as a leader within this field.”

Novozymes led its sector from 2000 to 2007. Now, in 2009, Novozymes has again been ranked the leader of the Biotechnology sector because it has improved its scores covering all three dimensions: environmental, social, and economic.

About the Dow Jones Index and SAM
Launched in 1999, the Dow Jones Sustainability World Index (DJSI World) comprises the leading companies in terms of sustainability around the world. Based on long-term economic, environmental, and social criteria, it captures the top 10% of the biggest 2,500 companies worldwide.

SAM is an investment group focused exclusively on sustainability investing and provides asset managers with benchmarks to manage sustainability portfolios. SAM partners with Dow Jones Indexes and STOXX Limited to publish and license the globally recognized Dow Jones Sustainability Indexes (DJSI).

Read more about the 2009 index results in a media release published by Dow Jones, STOXX, and SAM on